Click the icons below to search through Pioneer’s reports and documents.
- Are Drug Prices Driving Healthcare Cost Growth? (2750)
- Key Questions for Legislators on the Institute for Clinical and Economic Review (ICER) (2363)
- Looming Challenges for ICER in Assessing the Value of Rare Disease Therapies (346)
- Quality Adjusted Life Years (QALY): The Threat to Older Americans (35)
- The Legality of QALY under the ADA (281)
- Transparency in Retail Drug Prices: Easy to Obtain but Accuracy May Be Doubtful (2865)
- Will New England See Lower Prices from Drug Pricing Transparency Legislation? (1642)